3-D Matrix

Date: Thursday 8 October
Time: 09:00-10:15
Room: 212

The Use of a Novel Self-Assembling Peptide for Haemostasis in Cardiac Surgery

Moderator: Professor Roussel

Introduction to PuraStat
Professor Roussel

Perspectives on PuraStat
Professor Di Bartolomeo

Overview of the Clinical Data
Professor Ohri

Above and Beyond with PuraStat
Dr Astudillo

Summary & Live Q&A

Abbott

Date: Thursday 8 October
Time: 09:00-10:15
Room: 118/119

Surgical aortic valve replacement: how to manage past, present and future.

Michael Borger, Germany

Introduction
Michael Borger, Germany

How long do Tissue Heart Valves really last?
Gebrine El Khoury, Belgium

Valve-in-Valve, what’s the latest evidence?
Danny Dvir, Israel

Mechanical Heart Valves: why and when?
Angel Gonzalez Pinto, Spain

Conclusion
Michael Borger, Germany

Please click HERE for the PDF programme.

Abiomed

Date: Thursday 8 October
Time: 09:00-10:15
Room: 116/117

From bridging to next Tx to native heart recovery – are there new options?

Moderators: Professor Daniel Zimpfer; Professor Bart Meyns

What to do in Patients with severe Myocarditis that still have a chance to recover?
Professor Payam Akyhari

Optimizing patient management of midterm PCMS in patients undergoing complex cardiac surgery anticipating a longer path towards recovery.
Dr Alexander Bernhardt

The surgical perspective on right heart failure.
Professor Christoph Starck

LivaNova

Date: Thursday 8 October
Time: 09:00-10:15
Room: 211

When complex can be simpler – The Perceval Platform

Moderator: Professor Bart Meuris, Leuven, Belgium

Minimized incision – maximized vision: an ideal approach for Perceval
Dr Alaaddin Yilmaz, Hasselt, Belgium

Multimodal Valve Therapy: The 360° Approach with Perceval – optimizing MICS
Dr Manuel Wilbring, Dresden, Germany

Perceval (Plus) in multivalve procedures – When time really matters
Professor Alexander Weymann, Essen, Germany

Please click HERE for the PDF programme

Medtronic

Date: Thursday 8 October
Time: 09:00-10:15
Room: Forum

HEART TEAM DECISIONS IN TIMES OF EVOLVING INDICATIONS

Moderator: Professor T. Modine (Bordeaux, France)

Mini AVR in 2020 and beyond
Professor M. Di Eusanio (Ancona, Italy)

Expanding options for bicuspid aortic stenosis patients – TAVI or SAVR
Professor S. Bleiziffer (Bad Oeynhausen, Germany)

The Right choice for Low Risk aortic stenosis patients – TAVI or SAVR?
Professor T. Modine (Bordeaux, France)

Please click HERE for the PDF programme

Terumo Aortic

Date: Thursday 8 October
Time: 09:00-10:15
Room: 111/112

Past, present and future of aortic repair: from root to the descending thoracic aorta

Moderator: Dr Joseph Bavaria

UK Experience of FET for acute type A dissection – Thoraflex Hybrid vs Conventional Therapy
Dr Geoff Tsang

Mid-term results of orthotopic branched endovascular aortic arch repair: outcomes in 43 patients treated with RelayBranch in Europe and Japan
Professor Martin Czerny

The 20th Year Anniversary – Gelweave Valsalva the gold standard for valve sparing root surgery
Professor Ruggero De Paulis

Abbott

Date: Friday 9 October
Time: 13:15-14:30
Room: 111/112

Surrounding advanced Heart Failure

Moderators: Ivan Netuka, Czech Republic; Daniel Zimpfer, Austria 

Introduction
Ivan Netuka, Czech Republic; Daniel Zimpfer, Austria 

Improving Outcomes of advanced heart failure patients by means of advanced surgical approaches
Daniel Zimpfer, Austria

Bridging patients from ECMO to LVAD: Best practices to ensure best outcomes
Ana Gonzales Román, Spain

COVID-19: The quest to avoid collateral damages to patients in need of advanced HF therapies
Marie-Cecile Bories, France; Ramzi Abi Akar, France

Optimized patient management leading to superior outcomes with latest LVAD technologies
Ivan Netuka, Czech Republic

Closing
Ivan Netuka, Czech Republic; Daniel Zimpfer, Austria 

Please click HERE for the PDF programme

Abbott

Date: Friday 9 October
Time: 13:15-14:30
Room: Forum

The New Age of Transcatheter Mitral Valve Implantation

Moderators: Thomas Modine, France; Erwan Donal, France

Introduction
Thomas Modine, France

Integrating transcatheter mitral valve implantation therapy into surgical practice
Hendrik Treede, Germany

Determining anatomic suitability
Lenard Conradi, Germany

Optimizing post-op TMVI patient management
Gry Dahle, Norway

Conclusion
Erwan Donal, France

Please click HERE for the PDF programme

AtriCure

Date: Friday 9 October
Time: 13:15-14:30
Room: 211

Emerging Concepts of Hybrid AF options

Moderator: Professor Piotr Suwalski, Warsaw

Persistent AF, Why go Hybrid?
Professor Jaswinder Gill, London

New Approaches for Thoracoscopic Treatment of AF and the LAA
Dr Bart Maesen, Maastricht

Implementing a convergent procedure programme: Minimally invasive Hybrid procedure for Lone Atrial Fibrillation. The Convergent Procedure
Mr Aziz Momin, London

Importance of the Team Approach for Convergent Hybrid AF Ablations
Dr Riyaz Kaba, London

CytoSorbents

Date: Friday 9 October
Time: 13:15-14:30
Room: 212

Actual data and clinical experiences on CytoSorb hemoadsorption in various cardiac surgery indications*

Moderators: Jan Gummert, Bad Oeynhausen; Christophe Baufreton, Angers

Mitral valve endocarditis – new chances to improve the outcome
Daniel Wendt, Essen

Aortic surgery – modulation of the inflammatory response
Yahtin Mehta, Gurgaon

Removal of Ticagrelor during emergency heart surgery – reduction of complications and costs
Stephan Geidel, Hamburg

The special case: Successful treatment of rhabdomyolysis following heart transplantation
Udo Boeken, Duesseldorf

*Simultaneous translation is available for this symposium

Edwards Lifesciences

Date: Friday 9 October
Time: 13:15-14:30
Room: 116/117

Treatment of aortic stenosis: new learnings for the decade

Moderator: Jose L Pomar

Place of surgical AVR in octogenarians and nonagenarians in 2020: state of the art.
Krzysztof Bartus

Structural valve deterioration. What is the next step after VARC 2 guidelines.
Philippe Pibarot

Prevention of thromboembolic events following AVR: aspirin/anti vitamin K/NOAC. Where are we standing?
Nikolaos Bonaros

INSPIRIS RESILIA aortic valve: a clinical body of evidence.
Martin Andreas

Please click HERE for the PDF programme

Medtronic

Date: Friday 9 October
Time: 13:15-14:30
Room: 118/119

OPTIMAL CARDIAC SURGICAL CARE – ARE WE THERE YET?

Moderators: Professor Michael Borger; Professor Thomas Modine

Clinical performance of the Avalus Pericardial Aortic Valve after four years
Professor Robert Klautz

A standardized epicardial concept for the standalone treatment of longstanding-persistent AF – evolution of a procedure with added value
Dr Niels Verberkmoes

Optimizing tricuspid repair: initial experience with the new Tri-Ad 2.0 annuloplasty band
Professor Omer Dzemali

Panel discussion

Please click HERE for the PDF programme

Medtronic

Date: Friday 9 October
Time: 13:15-14:30
Room: 120

THE HVAD™ SYSTEM: EXPERTS SHARE EXPERIENCES WITH 10 YEARS OF RELIABILITY, VERSATILITY AND SMART TECHNOLOGY

Moderator: Professor Stephan Schueler (Newcastle, UK)

Introduction
Professor Stephan Schueler (Newcastle, UK)

A decade of worldwide clinical experience and data from a single center in using HVAD
Professor Evgenij Potapov (Berlin, Germany)

Enhanced versatility of the HVAD allows the treatment of complex cardiac disease and less traumatic surgical implantation techniques have improved long term outcomes
Professor Daniel Zimpfer (Vienna, Austria)

Unique inbuilt monitoring technology for precise hemodynamic control and novel innovations will take longterm LVAD therapy to a new level – An outlook
Dr Sebastian Schulte Eistrup (Bad Rothenfelde, Germany)

Panel discussion
Dr Khaldoon Alhumood (Kuwait-City, Kuwait); Dr Meindert Palmen, (Leiden, The Netherlands); Thomas Schlöglhofer, MSc. (Vienna, Austria)

Please click HERE for the PDF programme